about
Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans?Germline BAP1 mutations predispose to malignant mesotheliomaMalignant mesothelioma: facts, myths, and hypothesesOccupational exposure to carcinogens: Benzene, pesticides and fibers (Review)miR-1 induces growth arrest and apoptosis in malignant mesotheliomaTargeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotideFactors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data.Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) databaseImmune enhancement of skin carcinogenesis by CD4+ T cells.Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report.Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesotheliomaMET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.Malignant pleural mesothelioma: an epidemiological perspectiveValidation of genomics-based prognostic tests in malignant pleural mesothelioma.Clinical significance of soluble CD26 in malignant pleural mesothelioma.Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma.Malignant pleural mesothelioma--an update.A novel link between FMR gene and the JNK pathway provides clues to possible role in malignant pleural mesothelioma.Transcriptome sequencing of malignant pleural mesothelioma tumorsChrysotile as a cause of mesothelioma: an assessment based on epidemiology.Emerging drugs for mesothelioma.Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change?Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.Expression of cancer-associated molecules in malignant mesotheliomaActivated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.New diagnostic and molecular characteristics of malignant mesothelioma.The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.Antitumor activity of anti-C-ERC/mesothelin monoclonal antibody in vivo.Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973-2012).An unusual cause of an anterior mediastinal mass.The development of MM is strongly correlated with exposure to asbestos and erionite, as well as to simian virus 40”.Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.Chrysotile and rock wool fibers induce chromosome aberrations and DNA damage in V79 lung fibroblast cells.First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.Incidence trends of mesothelioma in Norway, 1965-1999.
P2860
Q23917643-CF6EE80F-CA93-417B-BD60-C686FF8ADC3DQ24635326-D1C59F19-F768-4E57-AAF1-A38A20AC6B1FQ28390539-676074F8-E9B4-4876-A1B5-6A9D5D1464A9Q28393587-B485647F-9E4B-4B82-9A67-B55A1C044DD2Q28397782-4882A1AB-EA9D-4492-84DD-341FE631F80EQ28535212-957F3E92-F2C9-4663-AD7E-0060E7CB5946Q31054381-AFF82B11-1842-43F2-841C-9F49DCCDCBF1Q31117531-0082796A-AC1B-47F3-A0D5-D97236DF144BQ33186709-5C85465D-67FA-4BDE-ACBA-A8D956E7CD96Q33266936-E004F3FA-CCDD-44BB-A31A-5A7E66592A9CQ33555260-9AA82379-236B-4AE6-8254-CD8037A58792Q34182679-021EE35C-D587-4FC1-982C-617DD104B9C1Q34343218-8A0417B8-5CBD-4C06-AC04-FBE877907791Q34366730-3BD12BC5-B157-4D92-AA19-FA0908A1362CQ34715788-F710E2E9-AB20-4DC5-92CE-4085C67D2CAFQ34744092-FCB1D43D-485F-483A-8A1C-97E6FCC15D5DQ35591904-A2985899-9355-427C-9FD2-A9AC6E5FCDBAQ35740408-DE16873F-EE0E-4F94-AA43-B7B216E93967Q36042626-BF1F3240-6428-43EF-ADA6-586F6674E40BQ36491120-6474CA25-2CE9-46AD-A669-3C53B630B998Q36493577-515E6918-EBC4-401D-8D25-2D9797F3602AQ36758593-1DEF7F55-3B69-4A6D-A98B-F451D1037366Q36812903-9907B7BC-B947-404A-9E70-D5893295CE82Q37271498-1B9A4C9D-D5BD-4AFD-9212-A9AFFDD8610DQ37281015-406CAFC6-0DE5-4A17-ADE0-755DAECA3B3EQ37287506-ACBD8317-0711-4DBA-BE04-A2312A5241CDQ37360580-70BE9D01-ADD5-475C-A2CD-071E9F0BDD76Q37813173-8D23C207-6DFA-4EEB-8841-B4793E01D33AQ38849249-D98C3F67-2EF0-4E22-AD2C-4A60959D67A3Q38870822-E10F58BE-91B4-415E-A750-FE2059EFA35FQ38959812-9C276257-3A95-44D8-B3AE-B0E009E1B8DFQ39006692-7053E6E3-5718-4819-AEB3-76B78D8BB58EQ39748254-4CE68DE8-7F00-4765-9E58-4074BF7C0946Q40501433-B2791BAC-3ABA-4966-899B-829169C66266Q40823289-080B78DD-1559-4D0F-A293-1967ED12B8DDQ42043894-D641CAE2-6AE2-4EFE-86C5-144D9E36ADECQ43239330-31F3C0CD-1A09-4409-8898-87DB51780359Q43363915-C28E63EF-1B9D-436F-A515-258E9FFFE3D8Q47868774-6C05AED1-E6F2-4592-AE93-0CBC872AF39AQ50724265-202119F4-5CE4-498D-9193-03676F37371A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The epidemiology of mesothelioma.
@ast
The epidemiology of mesothelioma.
@en
The epidemiology of mesothelioma.
@nl
type
label
The epidemiology of mesothelioma.
@ast
The epidemiology of mesothelioma.
@en
The epidemiology of mesothelioma.
@nl
prefLabel
The epidemiology of mesothelioma.
@ast
The epidemiology of mesothelioma.
@en
The epidemiology of mesothelioma.
@nl
P356
P1433
P1476
The epidemiology of mesothelioma.
@en
P2093
Mark Britton
P356
10.1053/SONC.2002.30237
P577
2002-02-01T00:00:00Z